McIlrath & Eck, LLC
- SEC CIK
- 0001701714
- Latest filing
- May 19, 2026
DXCM holding history
Dexcom Inc in every 13F filed by McIlrath & Eck, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DXCM overviewAll 13F holders of DXCMFull Q1 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 16
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −80−100.0% | Sold out | Holders |
| Q4 2024 | 80 | $6.22K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 80 | $5.36K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 80 | $9.07K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 80 | $11.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 80 | $9.93K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 80 | $7.46K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 80 | $10.3K | <0.1% | −6−7.0% | Reduced | Holders |
| Q1 2023 | 86 | $9.99K | <0.1% | +6+7.5% | Added | Holders |
| Q4 2022 | 80 | $9.06K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 80 | $6.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 80 | $6.00K | <0.1% | 00.0% | UnchangedConverted for a 4-for-1 split | Holders |
| Q1 2022 | 20 | $10.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 20 | $11.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 20 | $11.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 20 | $9.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 20 | $7.00K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.